Immune Checkpoint Blockade in Patients with Triple-Negative Breast Cancer Laura L. MichelAlexandra von AuAndreas Schneeweiss Review Article 08 June 2020 Pages: 415 - 428
Antibody–Drug Conjugates in Thoracic Malignancies: Clinical Trials Reveal Both Promise and Challenges Sandrine PayanMarc MontanaPatrice Vanelle Review Article 28 July 2020 Pages: 429 - 448
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance Emanuel RaschiMilo GattiFabrizio De Ponti Review Article Open access 28 July 2020 Pages: 449 - 466
Biologic Drug Quality Assurance to Optimize HER2 + Breast Cancer Treatment: Insights from Development of the Trastuzumab Biosimilar SB3 Diana LüftnerGary H. LymanMinji Seo Review Article Open access 03 August 2020 Pages: 467 - 475
Identifying Prostate Surface Antigen Patterns of Change in Patients with Metastatic Hormone Sensitive Prostate Cancer Treated with Abiraterone and Prednisone Iris Y. ShengJaleh FallahJorge A. Garcia Original Research Article 13 July 2020 Pages: 477 - 483
Real-World Outcomes of Pazopanib Treatment in Korean Patients with Advanced Soft Tissue Sarcoma: A Multicenter Retrospective Cohort Study Chung Ryul OhJung Yong HongJeong Eun Kim Original Research Article 30 June 2020 Pages: 485 - 493
Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis Roberto IacovelliChiara CiccareseGiuseppe Procopio Original Research Article 15 July 2020 Pages: 495 - 501
Post-Progression Survival in Secondary EGFR T790M-Mutated Non-Small-Cell Lung Cancer Patients With and Without Osimertinib After Failure of a Previous EGFR TKI Chi-Lu ChiangHsu-Ching HuangChao-Hua Chiu Original Research Article 21 July 2020 Pages: 503 - 512
Ceritinib-Induced Organizing Pneumonia in Lung Cancer: A Retrospective Analysis Wonyoung ChoiHyun-ju LimYoungjoo Lee Original Research Article 15 July 2020 Pages: 513 - 522
Comparison of Large, Medium, and Small Solid Tumor Gene Panels for Detection of Clinically Actionable Mutations in Cancer Eric VailJianbo SongJean R. Lopategui Original Research Article 08 August 2020 Pages: 523 - 530
Clinical Relevance of BRAF V600E Mutation Status in Brain Tumors with a Focus on a Novel Management Algorithm Adam KowalewskiJustyna DurślewiczŁukasz Szylberg Therapy in Practice Open access 09 July 2020 Pages: 531 - 540
Untangling the Multidisciplinary Care Web: Streamlining Care Through an Immune-Related Adverse Events (IRAE) Tumor Board Laura C. KennedyKit Man WongPetros Grivas Therapy in Practice 24 July 2020 Pages: 541 - 548
Management of Adverse Events Associated with Cabozantinib Treatment in Patients with Advanced Hepatocellular Carcinoma Gabriel SchwartzJulianne O. DarlingLucia Damicis Therapy in Practice Open access 08 August 2020 Pages: 549 - 565